首页 正文

SGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018)

{{output}}
Introduction: The sodium-glucose co-transporter 2 (SGLT2) is ascribed to target renal tubular glucose re-absorption, and its inhibition has been proved to induce glucosuria which improves the glycemic index. Accordingly, SGLT2 in... ...